BDX

How BDX Has Actually Traded Around Earnings

Over the last eight reported quarters, BDX has beaten the consensus EPS estimate every single time — an 8-for-8 (100%) beat rate — with an average earnings surprise of 8.6%. On the surface, that suggests the company has consistently cleared Wall Street’s published bar. The average 5-day price move in the five trading days after those reports has been +3.95%, classified as an “up” drift. But those averages hide an important wrinkle: the post-earnings reaction has not always followed the direction of the beat.

Look at the four most recent quarters. On May 7, 2026, BDX reported EPS of $2.90 versus an estimate of $2.78, a 4.3% beat — yet the stock fell 2.5% the next day and was down 5.74% over the following five sessions. Three months earlier, on Feb. 9, 2026, the company earned $2.91 against a $2.21 estimate, a 31.7% surprise; the stock rose 5.3% the next day and 8.8% over the next five days. The Nov. 6, 2025 quarter showed $3.96 versus $3.92, just a 1% beat, with a muted next-day gain of 0.25% but a strong 8.82% five-day drift. And on Aug. 7, 2025, a $3.68 print versus a $3.40 estimate (8.2% surprise) produced a 3.1% next-day pop and a 3.9% five-day move. The takeaway is that even when BDX beats, the price path is mixed quarter to quarter, so the headline result is only part of the story.

Options-Flow Dynamics Into the Aug. 6 Report

BDX is scheduled to report next on Aug. 6, 2026, before the open, with a consensus EPS estimate of $3.14. Given the 8-for-8 beat streak and the 8.6% average surprise, derivative markets may price elevated expectations heading into the print. In cases like this, the market’s real expectation can sometimes run above the published consensus — especially if call flow, implied volatility skew, or weekly option positioning is stacking on one side. Traders typically watch for unusual volume in near-dated options, changes in implied volatility, and whether the expected move implied by the straddle lines up with the historical 5-day average of 3.95%.

Current snapshot data shows BDX at $165.62, with the 50-day EMA at $154.37 and RSI at 63.8. That RSI level is not extreme, but it does show the stock has already moved and may have some positioning baked in. Healthcare / Medical – Instruments & Supplies peers sometimes trade on guidance as much as on the EPS beat itself, so flow around BDX should also be read against how the sector has been repricing recently.

What a Disciplined Trader Watches

Because BDX has beaten in every one of the last eight quarters but still produced a negative five-day drift as recently as May 2026, a disciplined approach treats the earnings print as a catalyst, not a guarantee. Traders usually compare the initial move to the prior closing price — for example, the Aug. 7, 2025 reaction opened +3.1% and extended to +3.9% over five days, while the May 7, 2026 reaction reversed hard — and then evaluate whether follow-through volume supports continuation or reversal.

Key items to monitor include the size of the beat versus expectations, any guidance revision, the first hour’s volume relative to the 20-day average, and whether the stock holds or gives back its opening gap. The 50-day EMA at $154.37 can serve as a reference for the prevailing trend, while the post-earnings window over the following five days is the interval that has historically produced the +3.95% average drift. Watching how BDX behaves inside that window matters as much as the headline number.

For a deeper look at how institutional research, options positioning, and sell-side models are interpreting the Aug. 6 setup, review the full institutional verdict on the ticker page.